Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic.

Circulation - 12 Sept 2017

McNally Elizabeth M, Wyatt Eugene J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dystrophin
Share to Genetic Predisposition to Disease
Share to Morpholinos
Share to Muscular Dystrophy, Duchenne

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Recovery of Function

Share to Translational Research, Biomedical

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 28893959
DOI: 10.1161/CIRCULATIONAHA.117.028382
PMCID: PMC5657589

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic.PMID 28893959Read ↗

Recent Trends in Antisense Therapies for Duchenne muscular dystrophySemantic proximity Read ↗

Recent advances in antisense oligonucleotide therapy in genetic neuromuscular diseasesSemantic proximity Read ↗

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophySemantic proximity Read ↗

RNA-targeted drugs for neuromuscular diseasesSemantic proximity Read ↗

Toward an Oligonucleotide Therapy for Duchenne Muscular Dystrophy: A Complex Development ChallengeSemantic proximity Read ↗

[Antisense oligos for muscular dystrophy].Semantic proximity Read ↗

Antisense Oligonucleotide-Based Therapy for Neuromuscular DiseaseSemantic proximity Read ↗

[Molecular therapy for duchenne muscular dystrophy].Semantic proximity Read ↗

Progress in therapeutic antisense applications for neuromuscular disorders.Semantic proximity Read ↗

Emerging Oligonucleotide Therapeutics for Rare Neuromuscular DiseasesSemantic proximity Read ↗

Exon skipping: a first in class strategy for Duchenne muscular dystrophySemantic proximity Read ↗

Therapeutic Potential of Tricyclo-DNA antisense oligonucleotidesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.